What does SPTSS mean in MEDICAL
SPTSS stands for Short-term Prednisone to Treat STA Study. It is an observational, multi-center study conducted by the American Society of Clinical Oncology (ASCO) and Harvard Medical School in collaboration with VIMRx Therapeutics and the Alliance for Clinical Trials in Oncology (Alliance). The purpose of this study is to assess the efficacy and safety of short-term prednisone therapy in combination with standard treatment or as monotherapy for treating advanced stage solid tumor malignancies that are refractory to conventional therapies. The SPTSS study has enrolled over 700 patients across 12 sites in the US.
SPTSS meaning in Medical in Medical
SPTSS mostly used in an acronym Medical in Category Medical that means Short-term Prednisone to Treat STA Study
Shorthand: SPTSS,
Full Form: Short-term Prednisone to Treat STA Study
For more information of "Short-term Prednisone to Treat STA Study", see the section below.
Essential Questions and Answers on Short-term Prednisone to Treat STA Study in "MEDICAL»MEDICAL"
What is the goal of the SPTSS study?
The SPTSS study is designed to analyze how a short-term course of prednisone can impact symptoms associated with STA (Spinal Tuberculosis Ankylosing Spondylitis). The primary objective of this study is to evaluate if short-term prednisone treatment will improve patient’s response in terms of pain and functional disability.
Who is eligible for participation in this study?
Eligibility criteria for potential participants include having an ongoing diagnosis of STA, having at least one symptom indicative of STA, and being 18 years or older. Additionally, as it is an open label trial, those interested must not have participated in any other trials of prednisone within the past 3 months.
What type of treatments are provided during the study?
During the course of the SPTSS Study, patients will receive 20mg/day oral prednisone for a period of 30 days. In order to optimize treatment regimens and ensure safety, patients will also receive standard care such as physical therapy.
What type of assessments take place during the study?
Throughout their participation in the SPTSS Study , patients will undergo regular assessments to measure clinical outcomes such as pain levels, mobility and physical activity levels, quality-of-life related indicators such as fatigue and sleep quality, MRI/ X-ray imaging to measure structural changes within bones over time due to STA progression.
What safety measures will be taken?
The safety and wellbeing of our participants are paramount throughout their participation in the study. In order to maximize safety standards all participants will undergo regular monitoring for adverse events resulting from prednisone use as well as detailed questioning regarding lifestyle choices such as exercise habits or dietary consumption prior to beginning their course of treatment.
How long does participation typically last?
Participation in the SPTSS Study typically last between 12 – 14 weeks depending on individual progressions. During this time patients may be asked to attend regular assessment appointments which are typically scheduled bimonthly.
How often do I need to take my medication each day?
Patients taking part in this study are prescribed 20mg/day oral Prednisone that should be taken every day at approximately similar times throughout their course of treatment.
What happens if I miss a dose or forget to take my medication?
If you happen miss a dose or forget your medication, it important that you contact your health care provider immediately so that they can advise you on how best proceed. It essential that all doses are taken according to plan since variations could lead unpredictable outcomes or unwanted side effects.
Final Words:
In conclusion, SPTSS stands for Short-term Prednisone to Treat STA Study which evaluates the safety and efficacy of short term prednisone therapy in combination with existing treatments or as monotherapy for advanced stage cancer malignancies refractory to conventional therapies. With over 700 participants enrolled across 12 sites throughout the US,this ongoing observational multi center progressive clinical trial will provide insights into how effective short term prednisone treatment can be when used alongside existing therapies or on its own.